Skip to content

Vitamin B12 Supplementation Study

Assessment of Functional Vitamin B12 Deficiency in Mexican Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00826657
Enrollment
180
Registered
2009-01-22
Start date
2004-10-31
Completion date
2006-11-30
Last updated
2015-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin B12 Deficiency

Keywords

B12 deficiency, methylmalonic acid, homocystein, vitamin B12 supplementation intervention

Brief summary

We hope to learn the clinical and functional signs of sub-clinical vitamin B12 deficiency and its response to supplementation in non-anemic, non-pregnant, and non-lactating women in Rural Mexico. Vitamin B12 is important in hematopoiesis, neuro-cognitive functions and genetic integrity. However vitamin B12 is only found in animal source foods therefore a large segment of the population in developing countries and those practicing vegetarianism are at risk of deficiency of the vitamin. This information will help decide weather supplementation with vitamin B12 is necessary in such populations for public health reasons.

Interventions

DIETARY_SUPPLEMENTVitamin B12

500 microgram daily supplement of vitamin B12 1000 mg injection vitamin B12 given at the start of the study

DIETARY_SUPPLEMENTplacebo

placebo given as a daily supplement 1000 mg injection of vitamin B12 given at the end of the study

Sponsors

USDA, Western Human Nutrition Research Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 59 Years
Healthy volunteers
Yes

Inclusion criteria

* Women age 20-59, apparently healthy, no severe B12 deficiency

Exclusion criteria

* pregnancy, lactation, anemia and disease states

Design outcomes

Primary

MeasureTime frame
response to B12 supplementation in serum B12, Methylmalonic acid, homocystein, and holotranscobalamin concentrations0 and 3 mos

Secondary

MeasureTime frame
DNA methylation change, and hematological response to B12 supplementation0 and 3 mos

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026